Daily Edition · Page 1

THE DAILY INDEX

Technology, AI, software, security, crypto and business

Across today’s newsletters

Today’s Index

TESLA SPENDS WEEKEND CUTTING PRICES OF CARS AND FSD SOFTWARE

Tesla has cut the prices of its models across China, Europe, and the US. Full Self-Driving is now $8,000 in the US. In China, the revamped Model 3 is now 241,900 yuan (~$32,000), down from 245,900 yuan previously and the Model Y was discounted to 249,900 yuan (~$34,500) from 263,900 yuan. The cheapest Model Y in the US is now $42,990. Tesla is facing several challenges, including a recall of almost 3,900 Cybertrucks, sales drops, interrupted production schedules, and more.

STOP GOING TO THE CLOUD AND GETTING SCAMMED. $200 INFRA TO SERVE YOUR STARTUP TILL 100K MONTHLY USERS IN 15 MINUTES

For many startups, the complexity and cost of cloud services can be replaced with a smaller, simpler setup. A self-hosted $200 infrastructure setup can easily handle up to 100k monthly users without breaking a sweat. The setup consists of PostgreSQL, a load-balanced API with automatic SSL using Caddyserver, and Docker for simple deployments and scaling.

ZKASINO $33 MILLION REDIRECTED TO LIDO

The launch of ZKasino, a decentralized gambling network, has sparked outrage among investors after the developers unexpectedly changed plans, preventing users from redeeming their bridged ether and instead automatically vesting it into $ZKAS tokens over a 15-month period. Despite warning signs and allegations of mismanagement, the project had initially attracted over $33 million from 10,000 participants. Following the controversial launch, the funds were sent to staking platform Lido, leading to widespread accusations of a rug pull and the cancellation of ZKasino's IDO and exchange listing.

GOOGLE'S TOP SECRET CAMERA LAB IS LIKE AN IKEA FOR PIXEL TESTING

Google's Real World Testing Lab is an elaborate environment where Google tests the cameras in its Pixel phones. The lab looks more like a cluster of Ikea displays than a testing room. It allows Google to test its devices in realistic environments that simulate where customers will actually use them. This article takes a look inside the lab and the kind of testing that Google does to make sure its devices capture moments in just the right way.

HOW MANY MORE OZEMPIC-LIKE DRUGS ARE IN THE PIPELINE — HERE'S WHAT RESEARCHERS ARE WORKING ON

Semaglutide has proved so successful that its manufacturer is unable to keep up with demand. There is currently a tsunami of clinical trials for new drugs that also operate on the gut-brain axis and re-create the action of other intestinal and pancreatic hormones. This article discusses the state of the industry and new developments on the horizon. These drugs remain inaccessible for many people due to cost.

TLDR IndexPage 1